Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: December 2014

Rapid Ebola Test Is Focus of NIH Grant to Rutgers Scientist

New Brunswick, NJ, December 9, 2014 ― A Rutgers researcher has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola.

David Alland, a professor of medicine and associate dean for clinical research at Rutgers New Jersey Medical School — and the principal investigator for the project — says health workers would be able to take the test to small villages and other remote locations where the spread of Ebola has been especially rampant and diagnose patients where they live. Continue reading

The Wall Street Journal Hosts CEO Council 2014: The CEOs’ List Top Priorities

New York, NY, December 9, 2014 ― More than 100 chief executives of large companies gathered at The Wall Street Journal’s annual CEO Council conference to discuss today’s pressing public-policy and business issues.

The CEOs divided into six task forces to debate priorities about:

  1. Doing business in China and what governments can do to help;
  2. How public companies can stay focused on the long term;
  3. The future of health care;
  4. Dealing with disruptive technology;
  5. Balancing energy security with environmental sustainability;
  6. How to expand middle-class jobs. Continue reading

Choose New Jersey CEO Tracye McDaniel to Return to Depart for New Position in Texas

Princeton, NJ, December 8, 2014 ― Choose New Jersey, Inc., a privately funded and operated nonprofit that works to grow investment and jobs in the Garden State, today announced the departure of its founding President and Chief Executive Officer, Tracye McDaniel.

She will be leaving the organization early next year to serve as President and Chief Executive Officer of the Texas Economic Development Corporation.  The Choose New Jersey Board of Directors has initiated a search for her successor. Continue reading

New Tracker Monitors the Performance of U.S. Health System

Washington, DC, December 8, 2014 ― The Kaiser Family Foundation, in partnership with the Peterson Center on Healthcare, has announced a new online hub dedicated to monitoring and assessing the performance of the US health system.

The Peterson–Kaiser Health System Tracker provides comprehensive data on how the system is performing on critical quality and cost measures, offering clear, up-to-date information on relevant trends, drivers and issues. Continue reading

The Hill Hosts ‘Rx Innovation: A Discussion on Biosimilars, Patient Access & Affordability’ Forum

Washington, DC, NY, December 8, 2014 ― As government and industry leaders look to rein in the cost of healthcare, The Hill convened a forward-looking conversation on biosimilar drugs and how they could affect healthcare access and affordability.

Forum participants, including the Pharmaceutical Research and Manufacturers of America (PhRMA), explored the potential cost savings of biosimilars, FDA approval processes for new medicines, and the state of the industry worldwide, among other topics. Continue reading

New Jersey Department of Health Encourages Residents to Get a Flu Vaccine

Trenton, NJ, December 8, 2014 ― The New Jersey Department of Health is reminding New Jerseyans that it is not too late to get a flu vaccine.  Flu activity usually peaks between December and February, but it can last as late as May.

As long as flu viruses are spreading and causing illness, vaccination can provide protection again the flu and should continue throughout the season.

National Influenza Vaccination Week (NIVW), December 7-13, 2014, is an opportunity to highlight the importance of receiving a yearly flu vaccine. Continue reading

Medical Innovation: Predicting Epileptic Seizures with 82 Percent Accuracy

Washington, DC, December 8, 2014 The Washington Report reports that there are 60 million epileptics on the planet, and while advances in medication and implantable devices have helped them, the ability to better detect and even predict when they will have debilitating seizures would be a significant improvement in their everyday lives.

Imagine, for example, if an epileptic knew with reasonable certainty that his next seizure would not occur for an hour or a day or a week.  That might allow him to run to the market or go out for the evening or plan a short vacation with less concern. Continue reading

FDA Tries to End Dispute Between Brand-Name and Generic Drug Makers

New York, NY, December 5, 2014 The Wall Street Journal’s Pharmalot reported that, in a bid to resolve a simmering dispute between brand-name and generic drug makers, the FDA has issued a so-called draft guidance that provides a road map for generic companies to obtain samples of medicines from brand-name rivals for product testing.

The agency is acting after vociferous complaints from generic drug makers that their brand-name counterparts have been exploiting an FDA risk-mitigation program, which is designed to boost patient safety, in order to thwart generic competition.

Brand-name drug makers are often required to develop such programs, which are known as REMS, when a medicine is approved for use, but may pose a safety risk. Typically, a REMS plan includes physician and patient education pointers, as well as requirements for monitoring distribution. Continue reading

Rider University Names Dr. Gregory G. Dell’Omo as Next President

Lawrenceville, NJ, December 5, 2014 ― The Rider University Board of Trustees announced yesterday the appointment of Gregory G. Dell’Omo, Ph.D., as Rider’s seventh president. Dell’Omo will succeed Mordechai Rozanski who is retiring on July 31, 2015.  Dell’Omo will assume the presidency on August 1, 2015.

Dell’Omo will step down from his position at Robert Morris University (RMU), in Pittsburgh, Pa., at the end of the 2014-2015 academic year.

Rozanski will remain at Rider through the end of July 2015. Rider University is currently celebrating its 150th anniversary, which will culminate with Dell’Omo’s official inauguration. Continue reading

CDC Says Deadlier Flu Season Is Possible

Washington, DC, NY, December 5, 2014 ― The New York Times reported that this year’s flu season may be deadlier than usual, and this year’s flu vaccine is a relatively poor match to a new virus that is now circulating, federal health officials warned on Thursday.

“Flu is unpredictable, but what we’ve seen thus far is concerning,” said Dr. Thomas R. Frieden, the director of the Centers for Disease Control and Prevention (CDC). Continue reading